Trivium Point Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Buy |
2,966
+93
| +3% | +$72.5K | 0.25% | 105 |
|
|
2025
Q1 | $2.37M | Buy |
2,873
+278
| +11% | +$230K | 0.29% | 97 |
|
|
2024
Q4 | $2M | Buy |
2,595
+1,004
| +63% | +$775K | 0.25% | 110 |
|
|
2024
Q3 | $1.29M | Buy |
1,591
+1,129
| +244% | +$916K | 0.18% | 140 |
|
|
2024
Q2 | $418K | Buy |
+462
| New | +$418K | 0.06% | 223 |
|
|
2022
Q2 | – | Sell |
-2,196
| Closed | -$672K | – | 223 |
|
|
2022
Q1 | $672K | Buy |
2,196
+1,339
| +156% | +$410K | 0.15% | 150 |
|
|
2021
Q4 | $237K | Buy |
+857
| New | +$237K | 0.05% | 213 |
|